546 results on '"Han, B"'
Search Results
2. Microplastics exposure influence the formation of calcium oxalate kidney stone through inducing renal injury
3. Characteristics of microplastics and their effects on phthalates and microbial activity in greenhouse soil after long-term planting
4. 70P Combination of EGFR-TKI and chemotherapy versus EGFR-TKI monotherapy as neoadjuvant treatment of stage III-N2 EGFR-mutant non-small cell lung cancer
5. Review of risk assessment for navigational safety and supported decisions in arctic waters
6. Microstructure and wear property of WMoTaNb refractory high entropy alloy coating by laser cladding
7. Effect of nano-SiO2 on mechanical properties, fluidity, and microstructure of superfine tailings cemented paste backfill
8. EP02.01-12 PEG2000-PLA-Based Nanoscale Polymeric Micellar Reduces Paclitaxel-Related Toxicity in Beagles
9. EP06.03-01 Genetic Characterization of Driving Metastasis in TP53-Mutant Non-small Cell Lung Cancer Patients
10. P2.09-40 Efficacy of Anlotinib in T790M-positive NSCLC Patients with Osimertinib Resistance: A Retrospective and Exploratory Study
11. 53 Intracranial hypertension following alitretinoin treatment for chronic hand eczema: a case report
12. P1.02-02 Co-inhibition of MEK/RTKs Pathways via Trametinib Plus Anlotinib forKRAS-Mutant NSCLC
13. EP11.02-06 Atezolizumab vs Single-Agent Chemo in NSCLC Patients Ineligible for a 1L Platinum Regimen: Asian Subgroup Analysis of IPSOS
14. EP11.02-03 First Line Sintilimab plus Anlotinib vs Platinum-based Chemotherapy in Metastatic NSCLC (SUNRISE): Updated Efficacy and Safety Analysis
15. P1.27-09 Efficacy and Safety of Aumolertinib as Adjuvant Therapy in Resectable Stage I NSCLC with High-grade Patterns and EGFR Mutations (APPOINT)
16. Analysis of the Measured FDG Uptake from the First-in-Human Clinical Trial of Biology-Guided Radiotherapy
17. Workflow Considerations for Biology-Guided Radiotherapy (BgRT) Implementation
18. First-Year Experience of IMRT/SBRT Treatments Using a Novel Biology-Guided Radiation Therapy System
19. P45 A phase 1/2 study of DYNE-251 in males with DMD mutations amenable to exon 51 skipping: DELIVER study design
20. Characterization of Biology-Guided Radiotherapy Accuracy as a Function of PET Tracer Uptake
21. Patient-Adaptive Automated Segmentation in Daily kVCT Images for Radiotherapy of Head and Neck and Prostate Cancer
22. Mitigation of IMRT/SBRT Treatment Planning Errors on the First Biology-Guided Radiotherapy System Using FMEA within Six Sigma Framework
23. Evaluation of Treatment Interruptions and Recovery during Biology-Guided Radiotherapy Delivery
24. Dosimetric Accuracy of Multi-Target Biology-Guided Radiotherapy Treatments in a Single Session
25. P50 A phase 1/2 randomized, placebo-controlled, multiple ascending dose study (ACHIEVE) of DYNE-101 in individuals with myotonic dystrophy type 1 (DM1)
26. Imaging Performance of the PET Scan on a Novel Ring Gantry-Based PET/CT Linear Accelerator System in the First-in-Human Study of Biology-Guided Radiotherapy
27. Intrafraction Dosimetric Evaluation of Biology-Guided Radiotherapy to a Target Under Respiratory Motion
28. Diagnostic Value of Computed Tomography Angiography for Infective Endocarditis After Right Ventricle Outflow Tract Repair
29. Proposed competencies for the performance of cardiovascular computed tomography in pediatric and adult congenital heart disease
30. Randomized phase II adjuvant trial to compare two treatment durations of icotinib (2 years versus 1 year) for stage II-IIIA EGFR-positive lung adenocarcinoma patients (ICOMPARE study)
31. Technical Recommendations for Computed Tomography Guidance of Intervention in the Right Ventricular Outflow Tract: Native RVOT, Conduits and Bioprosthetic Valves: A White Paper of the Society of Cardiovascular Computed Tomography (SCCT), Congenital Heart Surgeons’ Society (CHSS), and Society for Cardiovascular Angiography & Interventions (SCAI)
32. Technical Recommendations for Computed Tomography Guidance of Intervention in the Right Ventricular Outflow Tract: Native RVOT, Conduits and Bioprosthetic Valves
33. Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors
34. MO-0876 BIOGUIDE-X: A First-in-Human Study of the Performance and Safety of Biology-Guided Radiotherapy
35. 33P Real-world experience of MET TKI-induced peripheral edema
36. Green chemistry fabrication of durable antimicrobial peptide-immobilized silk fibroin films for accelerated full-thickness wound healing
37. Mitigation of IMRT/SBRT treatment planning errors on the novel RefleXion X1 system using FMEA within Six Sigma framework
38. 136P Tislelizumab (TIS) plus chemotherapy (chemo) for EGFR-mutated non-squamous non-small cell lung cancer (nsq-NSCLC) failed to EGFR tyrosine kinase inhibitors (TKIs) therapies: The primary analysis
39. 134P Safety and efficacy of multi-target TKI combined with nivolumab in checkpoint inhibitor-refractory advanced NSCLC patients: A prospective, single arm, two stage study
40. 59MO Final analysis of AK105-302: A randomized, double-blind, placebo-controlled, phase III trial of penpulimab plus carboplatin and paclitaxel as first-line treatment for advanced squamous NSCLC
41. 81P Is PD-1 inhibitor based treatment better than chemotherapy for metastatic NSCLC patients with PD-L1≥50% who develop EGFR-TKI resistance? A real-world investigation
42. Systematic Study of Patient-Specific Organs at Risk Auto-Segmentation on Daily kVCT Images for Adaptive Head and Neck Radiotherapy
43. Patient-Specific Auto-Segmentation of Target and OARs via Deep Learning on Daily Fan-Beam CT for Adaptive Prostate Radiotherapy
44. 355P Anlotinib plus standard chemotherapy as first-line treatment in extensive-stage small cell lung cancer patients
45. Cardiovascular computed tomography in pediatric congenital heart disease: A state of the art review
46. IMRT and SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System
47. EP16.02-023 Extracellular Vesicles Long RNA Sequencing as Diagnostic Biomarkers for Lung Adenocarcinoma Patients with Tumor Size Smaller than 2cm
48. EP08.01-042 NEPTUNE China Cohort: First-Line Durvalumab + Tremelimumab versus Chemotherapy in Chinese Patients with Metastatic NSCLC
49. EP08.01-102 Anlotinib Combined with PD-1 Inhibitors May Benefit Advanced Non-small Cell Lung Cancer Patients After Failure of EGFR-TKI Therapy
50. EP08.01-052 Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.